Navigation Links
Vanrx Pharmasystems comes to Interphex 2017 with growing momentum for its Aseptic Filling Workcells
Date:3/14/2017

VANCOUVER, March 14, 2017 /PRNewswire/ - Vanrx Pharmasystems comes to exhibit at Interphex 2017 with growing adoption of its SA25 Aseptic Filling Workcell. The system is the first gloveless robotic isolator for aseptic filling of injectable drug products.

Singota Solutions (Booth #1461) and AB Biotechnologies (Booth #1539) have each publicly announced their adoption of Vanrx's aseptic filling systems, with other U.S. and global installations also occurring this year. Consultations have occurred between Vanrx, customers and regulatory bodies, including the U.S. Food and Drug Administration (FDA), for use of the Vanrx SA25 in clinical and commercial production.

Continue Reading
The Vanrx SA25 Aseptic Workcell is the first gloveless robotic isolator for automated filling of injectable or lyophilized therapies. At Interphex 2017, Vanrx will be showing the SA25 in its unique virtual reality experience. The SA25 fills syringes, vials and cartridges, and has industry-leading decontamination and product changeover times. It is well-suited for the manufacture of targeted, smaller volume therapies that form an increasing portion of pharmaceutical companies’ revenues. (CNW Group/Vanrx Pharmasystems Inc.)
The Vanrx SA25 Aseptic Workcell is the first gloveless robotic isolator for automated filling of injectable or lyophilized therapies. At Interphex 2017, Vanrx will be showing the SA25 in its unique virtual reality experience. The SA25 fills syringes, vials and cartridges, and has industry-leading decontamination and product changeover times. It is well-suited for the manufacture of targeted, smaller volume therapies that form an increasing portion of pharmaceutical companies’ revenues....

"Vanrx is growing at a tremendous rate as the industry recognizes the value of the company's approach to flexible aseptic filling. This edition of Interphex is special because we have so much to share with companies that were waiting to see progress towards product and regulatory milestones," says Chris Procyshyn, CEO, Vanrx Pharmasystems.

Visitors to booth 3904 can see the SA25 Workcell in operation through the company's innovative virtual reality experience. Viewers go inside a real Workcell as robots perform the work of filling and closing nested, pre-sterilized vials.

Vanrx will also participate in the IPS technology tours for the first time as part of the "aseptic small-scale / modular technologies" segment on March 22 at 10 a.m. and 1 p.m.

The SA25 Aseptic Filling Workcell uses robotics to perform all material handling, filling and container closing activities. It was designed by pharmaceutical veterans who wanted to solve long-standing aseptic processing problems within conventional fill-finish systems. Their goal was to make the production of complex drug products easier and improve patient safety.

Key benefits of the SA25 Workcell include:

  • Flexibility to fill and close vials, syringes or cartridges with industry-leading quality.
  • Efficient production of multiple products through fast changeover and batch cycling times.
  • Shortens time to construct filling operations or add capacity through a standardized design.
  • Scale production through additional Workcells to support flexible manufacturing capacity.
  • Lowers costs by using less space and requiring fewer utilities than conventional systems.
  • Use of nested components and closures simplifies material handling and minimizes particle generation

About Vanrx Pharmasystems

Vanrx Pharmasystems makes the most technologically advanced sterile filling solutions for the pharmaceutical industry. Vanrx fill-finish machines use isolated robotics and machine vision to automate the packaging of injectable drugs into nested vials, syringes, or cartridges. The company was founded by pharmaceutical industry veterans to create the systems needed to make the next generation of innovative therapies. For more information, visit www.vanrx.com.


'/>"/>
SOURCE Vanrx Pharmasystems Inc.
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy
2. CVSL Inc. Name Change Becomes Official
3. PharmaRoth Labs Welcomes Two Respected Physicians to Board of Advisors
4. Mirixa and PDX Establish Relationship to Improve Patient Outcomes
5. Mobile Health (mHealth) - Enhancing Healthcare and Improving Clinical Outcomes
6. New Era in Medicine Comes to Arizona
7. CureMD Becomes the Exclusive Provider of 4,400 Mitochon Free EMR Users
8. FDA Approvals, Diversified Product Pipeline, Produce Sales Growth, and Positive Study Outcomes - Research Report on Boston Scientific, Zimmer, St. Jude, ResMed, and GenMark
9. Hal Sutton Becomes Spokesperson for Stryker Orthopaedics
10. New Data From Partners Center For Connected Health Demonstrates Wireless Mobile Technology Improves Patient Engagement, Outcomes
11. Permobil Becomes Premiere-Level Partner of The ALS Association; Will Offer Support for People Affected by Lou Gehrigs Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... , Oct. 11, 2017  Caris Life Sciences ® ... fulfilling the promise of precision medicine, today announced that ... Caris, Precision Oncology Alliance™ (POA) as its 17 th ... the St. Jude Crosson Cancer Institute will help develop ... use of tumor profiling, making cancer treatment more precise ...
(Date:10/10/2017)... ORANGE COUNTY, Calif. , Oct. 10, 2017  NDS received ... Mobile  — a medical-grade battery-powered display stand specifically designed for ... aims to transform technology into a clinical solution to support the ... costs. Innovative Design ... NDS ZeroWire Mobile Wireless Solution ...
(Date:10/5/2017)... Oct. 5, 2017  In response to the ... and Maxillofacial Surgeons (AAOMS) released prescribing recommendations that ... be used as a first-line therapy to manage ... Recognizing the value and ... Paper "Opioid Prescribing: Acute and Postoperative Pain Management" ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), ... of an innovative new design of the shoulder pad. The shoulder pad provides ... while controlling your pain while using cold therapy. By utilizing ice and water that ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
(Date:10/12/2017)... ... , ... Leading pediatric oncology experts at Children’s National Health System ... of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by ... Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief of the ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... nation's first interactive health literacy software tool, and the Cancer Patient Education Network ... cancer patient education, today announce a new strategic alliance. , As CPEN’s ...
(Date:10/12/2017)... D.C. (PRWEB) , ... October 12, 2017 , ... ... Cal Dining at the University of California Berkeley, and other leading institutions in ... the buying power of institutions to change the way animals are raised for ...
Breaking Medicine News(10 mins):